149 related articles for article (PubMed ID: 28246585)
1. Nanoparticle-linked antagonist for leptin signaling inhibition in breast cancer.
Harmon T; Harbuzariu A; Lanier V; Lipsey CC; Kirlin W; Yang L; Gonzalez-Perez RR
World J Clin Oncol; 2017 Feb; 8(1):54-66. PubMed ID: 28246585
[TBL] [Abstract][Full Text] [Related]
2. Leptin-Notch signaling axis is involved in pancreatic cancer progression.
Harbuzariu A; Rampoldi A; Daley-Brown DS; Candelaria P; Harmon TL; Lipsey CC; Beech DJ; Quarshie A; Ilies GO; Gonzalez-Perez RR
Oncotarget; 2017 Jan; 8(5):7740-7752. PubMed ID: 27999190
[TBL] [Abstract][Full Text] [Related]
3. Leptin-induced Notch and IL-1 signaling crosstalk in endometrial adenocarcinoma is associated with invasiveness and chemoresistance.
Daley-Brown D; Harbuzariu A; Kurian AA; Oprea-Ilies G; Gonzalez-Perez RR
World J Clin Oncol; 2019 Jun; 10(6):222-233. PubMed ID: 31367531
[TBL] [Abstract][Full Text] [Related]
4. Leptin-signaling inhibition results in efficient anti-tumor activity in estrogen receptor positive or negative breast cancer.
Rene Gonzalez R; Watters A; Xu Y; Singh UP; Mann DR; Rueda BR; Penichet ML
Breast Cancer Res; 2009; 11(3):R36. PubMed ID: 19531256
[TBL] [Abstract][Full Text] [Related]
5. Effects of leptin on human breast cancer cell lines in relationship to estrogen receptor and HER2 status.
Ray A; Nkhata KJ; Cleary MP
Int J Oncol; 2007 Jun; 30(6):1499-509. PubMed ID: 17487372
[TBL] [Abstract][Full Text] [Related]
6. Calycosin inhibits triple-negative breast cancer progression through down-regulation of the novel estrogen receptor-α splice variant ER-α30-mediated PI3K/AKT signaling pathway.
Li Y; Hu S; Chen Y; Zhang X; Gao H; Tian J; Chen J
Phytomedicine; 2023 Sep; 118():154924. PubMed ID: 37393829
[TBL] [Abstract][Full Text] [Related]
7. Combination Treatment with EGFR Inhibitor and Doxorubicin Synergistically Inhibits Proliferation of MCF-7 Cells and MDA-MB-231 Triple-Negative Breast Cancer Cells In Vitro.
Abrahams B; Gerber A; Hiss DC
Int J Mol Sci; 2024 Mar; 25(5):. PubMed ID: 38474312
[TBL] [Abstract][Full Text] [Related]
8. Iron oxide nanoparticles induce ferroptosis via the autophagic pathway by synergistic bundling with paclitaxel.
Nie Q; Chen W; Zhang T; Ye S; Ren Z; Zhang P; Wen J
Mol Med Rep; 2023 Oct; 28(4):. PubMed ID: 37681444
[TBL] [Abstract][Full Text] [Related]
9. Targeting EGFR of triple-negative breast cancer enhances the therapeutic efficacy of paclitaxel- and cetuximab-conjugated nanodiamond nanocomposite.
Liao WS; Ho Y; Lin YW; Naveen Raj E; Liu KK; Chen C; Zhou XZ; Lu KP; Chao JI
Acta Biomater; 2019 Mar; 86():395-405. PubMed ID: 30660004
[TBL] [Abstract][Full Text] [Related]
10. Obesity induced a leptin-Notch signaling axis in breast cancer.
Battle M; Gillespie C; Quarshie A; Lanier V; Harmon T; Wilson K; Torroella-Kouri M; Gonzalez-Perez RR
Int J Cancer; 2014 Apr; 134(7):1605-16. PubMed ID: 24114531
[TBL] [Abstract][Full Text] [Related]
11. Excellent effects and possible mechanisms of action of a new antibody-drug conjugate against EGFR-positive triple-negative breast cancer.
Zhou DD; Bai WQ; Zhai XT; Sun LP; Zhen YS; Li ZR; Miao QF
Mil Med Res; 2021 Dec; 8(1):63. PubMed ID: 34879870
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of GPR30 by estriol prevents growth stimulation of triple-negative breast cancer cells by 17β-estradiol.
Girgert R; Emons G; Gründker C
BMC Cancer; 2014 Dec; 14():935. PubMed ID: 25496649
[TBL] [Abstract][Full Text] [Related]
13. Leptin signaling promotes the growth of mammary tumors and increases the expression of vascular endothelial growth factor (VEGF) and its receptor type two (VEGF-R2).
Gonzalez RR; Cherfils S; Escobar M; Yoo JH; Carino C; Styer AK; Sullivan BT; Sakamoto H; Olawaiye A; Serikawa T; Lynch MP; Rueda BR
J Biol Chem; 2006 Sep; 281(36):26320-8. PubMed ID: 16825198
[TBL] [Abstract][Full Text] [Related]
14. Leptin-Notch axis impairs 5-fluorouracil effects on pancreatic cancer.
Harbuzariu A; Gonzalez-Perez RR
Oncotarget; 2018 Apr; 9(26):18239-18253. PubMed ID: 29719602
[TBL] [Abstract][Full Text] [Related]
15. Leptin-induced ER-α-positive breast cancer cell viability and migration is mediated by suppressing CCN5-signaling via activating JAK/AKT/STAT-pathway.
Haque I; Ghosh A; Acup S; Banerjee S; Dhar K; Ray A; Sarkar S; Kambhampati S; Banerjee SK
BMC Cancer; 2018 Jan; 18(1):99. PubMed ID: 29370782
[TBL] [Abstract][Full Text] [Related]
16. Elevated estrogen receptor β expression in triple negative breast cancer cells is associated with sensitivity to doxorubicin by inhibiting the PI3K/AKT/mTOR signaling pathway.
Lei S; Fan P; Wang M; Zhang C; Jiang Y; Huang S; Fang M; He Z; Wu A
Exp Ther Med; 2020 Aug; 20(2):1630-1636. PubMed ID: 32742395
[TBL] [Abstract][Full Text] [Related]
17. Leptin Signaling Affects Survival and Chemoresistance of Estrogen Receptor Negative Breast Cancer.
Lipsey CC; Harbuzariu A; Robey RW; Huff LM; Gottesman MM; Gonzalez-Perez RR
Int J Mol Sci; 2020 May; 21(11):. PubMed ID: 32471192
[TBL] [Abstract][Full Text] [Related]
18. Iron oxide nanoparticles loaded with paclitaxel inhibits glioblastoma by enhancing autophagy-dependent ferroptosis pathway.
Chen H; Wen J
Eur J Pharmacol; 2022 Apr; 921():174860. PubMed ID: 35278406
[TBL] [Abstract][Full Text] [Related]
19. Repurposing proteasome inhibitors for improved treatment of triple-negative breast cancer.
Larsson P; Pettersson D; Olsson M; Sarathchandra S; Abramsson A; Zetterberg H; Ittner E; Forssell-Aronsson E; Kovács A; Karlsson P; Helou K; Parris TZ
Cell Death Discov; 2024 Jan; 10(1):57. PubMed ID: 38286854
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of growth hormone receptor by Somavert reduces expression of GPER and prevents growth stimulation of triple-negative breast cancer by 17β-estradiol.
Girgert R; Emons G; Gründker C
Oncol Lett; 2018 Jun; 15(6):9559-9566. PubMed ID: 29805678
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
